IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT

Clinical trial NCT04522895 · COMPLETED

Trial details

NCT number: NCT04522895
Sponsor: Heinrich-Heine University, Duesseldorf
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia IDH2 Gene Mutation IDH2 R172 IDH2 R140

Start date: 2020-08-27
Primary completion: 2024-07-24
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.